News Releases

January 2018

January 5, 2018 1/5/2018 Takeda Announces Intention to Acquire TiGenix

November 2017

November 17, 2017 11/17/2017 Takeda and Cognition Kit Present Results from Digital Wearable Technology Study in patients with Major Depressive Disorder (MDD)

November 17, 2017 11/17/2017 The Boston Globe Names Takeda Pharmaceuticals U.S.A., Inc. a Top Place to Work for 2017

November 10, 2017 11/10/2017 The Chicago Tribune Names Takeda Pharmaceuticals U.S.A., Inc. A Workplace Achiever of the Chicago Area 2017 Top Workplaces Award

November 9, 2017 11/9/2017 New Post-Hoc Analysis Evaluating Deep Remission with Entyvio® (vedolizumab) in Patients with Moderately to Severely Active Ulcerative Colitis Recognized as “Poster of Distinction” at AIBD 2017 Annual Conference

October 2017

October 24, 2017 10/24/2017 Takeda, Lundbeck and Advocate Health Care Research Study Aims to Enhance Patient-Provider Engagement in Major Depressive Disorder Treatment using Digital Technology

October 16, 2017 10/16/2017 New Post-Hoc Analyses Report Early Symptomatic Improvement in Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease Patients Taking Entyvio® (vedolizumab), Particularly in Biologic-Naïve Patients

October 6, 2017 10/6/2017 Takeda Donates $100,000 to Local, Regional Charities as Part of Company’s Takeda Cares Day Event